Midland, MI, United States of America

William Liechty

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Texas System. Active years: 2021.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of William Liechty

Introduction

William Liechty is a notable inventor based in Midland, MI (US). He has made significant contributions to the field of biomedical engineering, particularly in the delivery of therapeutics. His work focuses on innovative methods for delivering small interfering RNA and micro RNA, which are crucial for various medical applications.

Latest Patents

William Liechty holds a patent for the "Delivery of small interfering RNA and micro RNA through nanogels containing hydrophobic pseudo-peptides." This patent describes nanoscale, pH-responsive polycationic networks that are useful for the delivery of anionic biologic therapeutics and associated methods. This innovation represents a significant advancement in the field of drug delivery systems.

Career Highlights

Liechty is affiliated with the University of Texas System, where he continues to engage in research and development. His work has garnered attention for its potential to improve therapeutic outcomes in various medical treatments.

Collaborations

One of his notable collaborators is Nicholas Peppas, a prominent figure in the field of biomedical engineering. Their partnership has led to advancements in the understanding and application of drug delivery systems.

Conclusion

William Liechty's contributions to the field of biomedical engineering through his innovative patent and collaborations highlight the importance of research in developing effective therapeutic delivery methods. His work continues to pave the way for future advancements in medical technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…